| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.180.1.655 |
| P698 | PubMed publication ID | 18097068 |
| P2093 | author name string | Yuan Zhou | |
| Alexandre Pachot | |||
| Anne Tournadre | |||
| Myew-Ling Toh | |||
| Pierre Miossec | |||
| Marie-Angélique Cazalis | |||
| Saloua Zrioual | |||
| Vincent Miossec | |||
| P2860 | cites work | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 655-663 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood | |
| P478 | volume | 180 |
| Q35914585 | A Feedback Loop between Inflammation and Zn Uptake |
| Q62633597 | ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate |
| Q92511371 | Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type |
| Q37243055 | An overview of IL-17 function and signaling |
| Q34802798 | Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization |
| Q36825365 | Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study |
| Q33730117 | Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent |
| Q35522947 | Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis |
| Q49163947 | CysLT1 receptor antagonist alleviates pathogenesis of collagen-induced arthritis mouse model |
| Q47253021 | Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation |
| Q42558375 | Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. |
| Q47277628 | Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins |
| Q36999576 | Expression of interleukin-17RC protein in normal human tissues |
| Q38295616 | Focal bone involvement in inflammatory arthritis: the role of IL17. |
| Q35507974 | IL-17 Enhances Chemotaxis of Primary Human B Cells during Asthma |
| Q34019620 | IL-17 as a future therapeutic target for rheumatoid arthritis |
| Q61448774 | IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels |
| Q61651896 | IL-17 in the immunopathogenesis of spondyloarthritis |
| Q33610883 | IL-17 induces monocyte migration in rheumatoid arthritis |
| Q47649658 | IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice |
| Q38129869 | IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. |
| Q34058535 | IL-17RA signaling amplifies antibody-induced arthritis |
| Q24629783 | IL-17RC: a partner in IL-17 signaling and beyond |
| Q34062484 | IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? |
| Q37004125 | Identification of STOML2 as a putative novel asthma risk gene associated with IL6R. |
| Q37317215 | Immune regulation of bone loss by Th17 cells. |
| Q64084407 | Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis |
| Q90675719 | Interleukin 23 and autoimmune diseases: current and possible future therapies |
| Q37986587 | Interleukin-17 in inflammatory myopathies |
| Q35685792 | Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. |
| Q37114519 | Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice |
| Q49320250 | Involvement of soluble B7-H3 in combination with the serum inflammatory cytokines interleukin-17, -8 and -6 in the diagnosis of hepatocellular carcinoma |
| Q47349998 | Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model |
| Q40324830 | Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. |
| Q28740839 | Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis |
| Q36173100 | Responses of Multipotent Retinal Stem Cells to IL-1β, IL-18, or IL-17 |
| Q28068177 | Role of Interleukin 17 in Lung Carcinogenesis and Lung Cancer Progression |
| Q33728533 | Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression |
| Q38755912 | Selected cytokine pathways in rheumatoid arthritis |
| Q33685495 | Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation |
| Q37292433 | T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. |
| Q37324840 | T cells in rheumatoid arthritis |
| Q50199704 | TAOK1 negatively regulates IL-17-mediated signaling and inflammation |
| Q38047820 | Targeting IL-17 and TH17 cells in chronic inflammation |
| Q37106755 | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis |
| Q37697039 | The IL-17 family cytokines in immunity and disease. |
| Q60919599 | The Interleukin-17 Family of Cytokines in Breast Cancer |
| Q26774681 | The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis |
| Q28066949 | The Role of Interleukin-17 in Lung Cancer |
| Q24594675 | The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases |
| Q37598359 | The role of T helper type 17 cells in inflammatory arthritis |
| Q38543052 | Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases |
| Q35012792 | Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. |
| Q39153776 | Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice |
Search more.